Vitexin (2 mg/kg, i.p., 4w) also inhibited NSCLC tumor growth, increased the expression levels of Bax and cleaved caspase‐3, and decreased the expression of Bcl‐2 in the tumor tissue of mice (Liu, Jiang, Liu, & Luo, 2019). The gene discussed is BAX; the disease is neoplasm.